000 03562nam a22003855i 4500
001 300795
003 MX-SnUAN
005 20160429155644.0
007 cr nn 008mamaa
008 150903s2011 gw | o |||| 0|eng d
020 _a9783642108587
_99783642108587
024 7 _a10.1007/9783642108587
_2doi
035 _avtls000354330
039 9 _a201509030508
_bVLOAD
_c201405060335
_dVLOAD
_y201402181015
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aRC254-282
100 1 _aSenn, Hans-Jörg.
_eeditor.
_9326161
245 1 0 _aClinical Cancer Prevention /
_cedited by Hans-Jörg Senn, Florian Otto.
264 1 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg :
_bImprint: Springer,
_c2011.
300 _ax, 162 páginas
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
490 0 _aRecent Results in Cancer Research,
_x0080-0015 ;
_v188
500 _aSpringer eBooks
505 0 _aAllocating cancer directed expenditures – Tensions between prevention, early detection and treatment -- Lessons learned from prevention programs: Different endpoints should be used in secondary and tertiary prevention -- Biomarkers for early detection and as surrogate endpoints in cancer prevention trials: Issues and opportunities -- Targeting polyamines and inflammation for cancer prevention -- Thinking about the role (largely ignored) of heavy metals in cancer prevention: Hexavalent chromium and melanoma as a case in point -- Hepatitis B virus and cancer prevention -- Chemoprevention of hepatocellular carcinoma in chronic hepatitis C -- Nutritional aspects of primary prostate cancer prevention -- Prostate cancer prevention with 5 alpha reductase inhibitors -- Hormone replacement therapy and breast cancer -- Physical activity and breast cancer: Review of the epidemiologic evidence and biologic mechanisms -- Prevention of breast cancer by newer SERMs and the future -- Chemoprevention of hormone receptor-negative breast cancer: new approaches needed.
520 _aThis book is based on presentations by some of the world’s leading experts at the Sixth International Conference on Clinical Cancer Prevention, held in St. Gallen, Switzerland, during March 2010. The main themes are the latest advances in the prevention of breast and prostate cancer and the role of infection in the development of liver and gastric cancer. Special emphasis is given to perspectives on the chemoprevention of breast cancer, as the conference included an international consensus meeting on this subject. New research findings are presented and potentially more effective cancer prevention strategies are discussed, with careful consideration of controversies. The expertise of the contributors encompasses genetics and microbiology, epidemiology, and health economics, as well as clinical cancer prevention. This book will be of interest to all who wish to learn about the most recent progress in combating the development of cancer.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700 1 _aOtto, Florian.
_eeditor.
_9338389
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9783642108563
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-3-642-10858-7
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c300795
_d300795